ARF Brings Taste for a Change to Chicago June 9th


Abzyme Research Foundation Holds Taste For Change Benefit in Chicago

The Event Raises Funds and Awareness for Innovative Therapeutic HIV Vaccine Candidate

The Abzyme Research Foundation will host a benefit in Chicago to raise funds to propel HIV E-VAC, an innovative HIV vaccine candidate, into human trials. The work is being conducted at the University of Texas Houston Medical School and California Public Health Service with support from the National Institutes of Health.

Abzyme Research Foundation is committed to propelling HIV E-VAC into human trials because of its preclinical testing that show its incredible promise for both a prophylactic and therapeutic HIV vaccine. Despite over 27 million in NIH support of the past 25 years, the innovations of catalytic antibodies and covalent vaccination have not attracted the Pharmaceutical support of an industry discouraged by an inability to produce an effective HIV vaccine after 30 years of trying.

“We are so excited  to announce the launch of our Taste For Change Program in Chicago.  This grassroots wine tasting series to support a promising therapeutic HIV vaccine candidate has already launched in NYC, LA, Miami, and now we are thrilled to be launching in Chicago.

As Founder and Executive Director at ARF,  I am thrilled at the opportunity to connect  to Chicago and  share w the enthusiasm that has me fighting with everything I’ve got to make sure this vaccine makes it to trial.

“What’s the big deal?” you may ask.  My favorite piece of media to share is this CBS newstory entitled “Possible HIV Cure?’ (the most viewed YouTube clip under “hiv cure“).

For a modest $20 donation come taste delicious wines at Mini Bar paired with flatbread pizzas, tapas tastings, and small bites from Mini Bars delicious selection and TASTE FOR CHANGE.

RSVP on Facebook, and we look forward to seeing you there!”

Zachary Barnett, ARF.

@  Mini Bar      3341 N. Halsted    Thursday June 9th,  7-9pm.

ARF is funding advancing a promising new therapeutic HIV vaccine into human trials through a national grassroots event series.  Join us, and support hope for a future without HIV/AIDS.
To learn more about ARF and the vaccine  candidate HIV-EVAC , visit